Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
Diseases » Neurofibromatosis-1 » Country Statistics
 

Statistics by Country for Neurofibromatosis-1

Prevalance of Neurofibromatosis-1:

1 per 3,000 - 4,000 people suffer from neurofibromatosis type 1 worldwide, Genetics Home Reference website

Prevalance Rate for Neurofibromatosis-1:

approx 1 in 3,000 or 0.03% or 90,666 people in USA [about data]

Extrapolation of Prevalence Rate of Neurofibromatosis-1 to Countries and Regions:

WARNING! EXTRAPOLATION ONLY! NOT BASED ON COUNTRY-SPECIFIC DATA SOURCES. The following table attempts to extrapolate the above prevalence rate for Neurofibromatosis-1 to the populations of various countries and regions. These prevalence extrapolations for Neurofibromatosis-1 are only estimates, based on applying the prevalence rates from the US (or a similar country) to the population of other countries, and therefore may have very limited relevance to the actual prevalence of Neurofibromatosis-1 in any region:

Country/Region Extrapolated Prevalence Population Estimated Used
Neurofibromatosis-1 in North America (Extrapolated Statistics)
USA 97,885 293,655,4051
Canada 10,835 WARNING! (Details) 32,507,8742
Mexico 34,986 WARNING! (Details) 104,959,5942
Neurofibromatosis-1 in Central America (Extrapolated Statistics)
Belize 90 WARNING! (Details) 272,9452
Guatemala 4,760 WARNING! (Details) 14,280,5962
Nicaragua 1,786 WARNING! (Details) 5,359,7592
Neurofibromatosis-1 in Caribbean (Extrapolated Statistics)
Puerto Rico 1,299 WARNING! (Details) 3,897,9602
Neurofibromatosis-1 in South America (Extrapolated Statistics)
Brazil 61,367 WARNING! (Details) 184,101,1092
Chile 5,274 WARNING! (Details) 15,823,9572
Colombia 14,103 WARNING! (Details) 42,310,7752
Paraguay 2,063 WARNING! (Details) 6,191,3682
Peru 9,181 WARNING! (Details) 27,544,3052
Venezuela 8,339 WARNING! (Details) 25,017,3872
Neurofibromatosis-1 in Northern Europe (Extrapolated Statistics)
Denmark 1,804 WARNING! (Details) 5,413,3922
Finland 1,738 WARNING! (Details) 5,214,5122
Iceland 97 WARNING! (Details) 293,9662
Sweden 2,995 WARNING! (Details) 8,986,4002
Neurofibromatosis-1 in Western Europe (Extrapolated Statistics)
Britain (United Kingdom) 20,090 WARNING! (Details) 60,270,708 for UK2
Belgium 3,449 WARNING! (Details) 10,348,2762
France 20,141 WARNING! (Details) 60,424,2132
Ireland 1,323 WARNING! (Details) 3,969,5582
Luxembourg 154 WARNING! (Details) 462,6902
Monaco 10 WARNING! (Details) 32,2702
Netherlands (Holland) 5,439 WARNING! (Details) 16,318,1992
United Kingdom 20,090 WARNING! (Details) 60,270,7082
Wales 972 WARNING! (Details) 2,918,0002
Neurofibromatosis-1 in Central Europe (Extrapolated Statistics)
Austria 2,724 WARNING! (Details) 8,174,7622
Czech Republic 415 WARNING! (Details) 1,0246,1782
Germany 27,474 WARNING! (Details) 82,424,6092
Hungary 3,344 WARNING! (Details) 10,032,3752
Liechtenstein 11 WARNING! (Details) 33,4362
Poland 12,875 WARNING! (Details) 38,626,3492
Slovakia 1,807 WARNING! (Details) 5,423,5672
Slovenia 670 WARNING! (Details) 2,011,473 2
Switzerland 2,483 WARNING! (Details) 7,450,8672
Neurofibromatosis-1 in Eastern Europe (Extrapolated Statistics)
Belarus 3,436 WARNING! (Details) 10,310,5202
Estonia 447 WARNING! (Details) 1,341,6642
Latvia 768 WARNING! (Details) 2,306,3062
Lithuania 1,202 WARNING! (Details) 3,607,8992
Russia 47,991 WARNING! (Details) 143,974,0592
Ukraine 15,910 WARNING! (Details) 47,732,0792
Neurofibromatosis-1 in the Southwestern Europe (Extrapolated Statistics)
Azerbaijan 2,622 WARNING! (Details) 7,868,3852
Georgia 1,564 WARNING! (Details) 4,693,8922
Portugal 3,508 WARNING! (Details) 10,524,1452
Spain 13,426 WARNING! (Details) 40,280,7802
Neurofibromatosis-1 in Southern Europe (Extrapolated Statistics)
Greece 3,549 WARNING! (Details) 10,647,5292
Italy 19,352 WARNING! (Details) 58,057,4772
Neurofibromatosis-1 in the Southeastern Europe (Extrapolated Statistics)
Albania 1,181 WARNING! (Details) 3,544,8082
Bosnia and Herzegovina 135 WARNING! (Details) 407,6082
Bulgaria 2,505 WARNING! (Details) 7,517,9732
Croatia 1,498 WARNING! (Details) 4,496,8692
Macedonia 680 WARNING! (Details) 2,040,0852
Romania 7,451 WARNING! (Details) 22,355,5512
Serbia and Montenegro 3,608 WARNING! (Details) 10,825,9002
Neurofibromatosis-1 in Northern Asia (Extrapolated Statistics)
Mongolia 917 WARNING! (Details) 2,751,3142
Neurofibromatosis-1 in Central Asia (Extrapolated Statistics)
Kazakhstan 5,047 WARNING! (Details) 15,143,7042
Tajikistan 2,337 WARNING! (Details) 7,011,556 2
Uzbekistan 8,803 WARNING! (Details) 26,410,4162
Neurofibromatosis-1 in Eastern Asia (Extrapolated Statistics)
China 432,949 WARNING! (Details) 1,298,847,6242
Hong Kong s.a.r. 2,285 WARNING! (Details) 6,855,1252
Japan 42,444 WARNING! (Details) 127,333,0022
Macau s.a.r. 148 WARNING! (Details) 445,2862
North Korea 7,565 WARNING! (Details) 22,697,5532
South Korea 16,077 WARNING! (Details) 48,233,7602
Taiwan 7,583 WARNING! (Details) 22,749,8382
Neurofibromatosis-1 in Southwestern Asia (Extrapolated Statistics)
Turkey 22,964 WARNING! (Details) 68,893,9182
Neurofibromatosis-1 in Southern Asia (Extrapolated Statistics)
Afghanistan 9,504 WARNING! (Details) 28,513,6772
Bangladesh 47,113 WARNING! (Details) 141,340,4762
Bhutan 728 WARNING! (Details) 2,185,5692
India 355,023 WARNING! (Details) 1,065,070,6072
Pakistan 53,065 WARNING! (Details) 159,196,3362
Sri Lanka 6,635 WARNING! (Details) 19,905,1652
Neurofibromatosis-1 in Southeastern Asia (Extrapolated Statistics)
East Timor 339 WARNING! (Details) 1,019,2522
Indonesia 79,484 WARNING! (Details) 238,452,9522
Laos 2,022 WARNING! (Details) 6,068,1172
Malaysia 7,840 WARNING! (Details) 23,522,4822
Philippines 28,747 WARNING! (Details) 86,241,6972
Singapore 1,451 WARNING! (Details) 4,353,8932
Thailand 21,621 WARNING! (Details) 64,865,5232
Vietnam 27,554 WARNING! (Details) 82,662,8002
Neurofibromatosis-1 in the Middle East (Extrapolated Statistics)
Gaza strip 441 WARNING! (Details) 1,324,9912
Iran 22,501 WARNING! (Details) 67,503,2052
Iraq 8,458 WARNING! (Details) 25,374,6912
Israel 2,066 WARNING! (Details) 6,199,0082
Jordan 1,870 WARNING! (Details) 5,611,2022
Kuwait 752 WARNING! (Details) 2,257,5492
Lebanon 1,259 WARNING! (Details) 3,777,2182
Saudi Arabia 8,598 WARNING! (Details) 25,795,9382
Syria 6,005 WARNING! (Details) 18,016,8742
United Arab Emirates 841 WARNING! (Details) 2,523,9152
West Bank 770 WARNING! (Details) 2,311,2042
Yemen 6,674 WARNING! (Details) 20,024,8672
Neurofibromatosis-1 in Northern Africa (Extrapolated Statistics)
Egypt 25,372 WARNING! (Details) 76,117,4212
Libya 1,877 WARNING! (Details) 5,631,5852
Sudan 13,049 WARNING! (Details) 39,148,1622
Neurofibromatosis-1 in Western Africa (Extrapolated Statistics)
Congo Brazzaville 999 WARNING! (Details) 2,998,0402
Ghana 6,919 WARNING! (Details) 20,757,0322
Liberia 1,130 WARNING! (Details) 3,390,6352
Niger 3,786 WARNING! (Details) 11,360,5382
Nigeria 5,916 WARNING! (Details) 12,5750,3562
Senegal 3,617 WARNING! (Details) 10,852,1472
Sierra leone 1,961 WARNING! (Details) 5,883,8892
Neurofibromatosis-1 in Central Africa (Extrapolated Statistics)
Central African Republic 1,247 WARNING! (Details) 3,742,4822
Chad 3,179 WARNING! (Details) 9,538,5442
Congo kinshasa 19,439 WARNING! (Details) 58,317,0302
Rwanda 2,746 WARNING! (Details) 8,238,6732
Neurofibromatosis-1 in Eastern Africa (Extrapolated Statistics)
Ethiopia 23,778 WARNING! (Details) 71,336,5712
Kenya 10,994 WARNING! (Details) 32,982,1092
Somalia 2,768 WARNING! (Details) 8,304,6012
Tanzania 12,023 WARNING! (Details) 36,070,7992
Uganda 8,796 WARNING! (Details) 26,390,2582
Neurofibromatosis-1 in Southern Africa (Extrapolated Statistics)
Angola 3,659 WARNING! (Details) 10,978,5522
Botswana 546 WARNING! (Details) 1,639,2312
South Africa 14,816 WARNING! (Details) 44,448,4702
Swaziland 389 WARNING! (Details) 1,169,2412
Zambia 3,675 WARNING! (Details) 11,025,6902
Zimbabwe 1,223 WARNING! (Details) 1,2671,8602
Neurofibromatosis-1 in Oceania (Extrapolated Statistics)
Australia 6,637 WARNING! (Details) 19,913,1442
New Zealand 1,331 WARNING! (Details) 3,993,8172
Papua New Guinea 1,806 WARNING! (Details) 5,420,2802

About extrapolations of prevalence and incidence statistics for Neurofibromatosis-1:

WARNING! EXTRAPOLATED STATISTICS ONLY! Not based on data sources from individual countries. These statistics are calculated extrapolations of various prevalence or incidence rates against the populations of a particular country or region. The statistics used for prevalence/incidence of Neurofibromatosis-1 are typically based on US, UK, Canadian or Australian prevalence or incidence statistics, which are then extrapolated using only the population of the other country. This extrapolation calculation is automated and does not take into account any genetic, cultural, environmental, social, racial or other differences across the various countries and regions for which the extrapolated Neurofibromatosis-1 statistics below refer to. The extrapolation does not use data sources or statistics about any country other than its population. As such, these extrapolations may be highly inaccurate (especially for developing or third-world countries) and only give a general indication (or even a meaningless indication) as to the actual prevalence or incidence of Neurofibromatosis-1 in that region. These statistics are presented only in the hope that they may be interesting to some people.

About prevalence and incidence statistics in general for Neurofibromatosis-1:

The word 'prevalence' of Neurofibromatosis-1 usually means the estimated population of people who are managing Neurofibromatosis-1 at any given time (i.e. people with Neurofibromatosis-1). The term 'incidence' of Neurofibromatosis-1 means the annual diagnosis rate, or the number of new cases of Neurofibromatosis-1 diagnosed each year (i.e. getting Neurofibromatosis-1). Hence, these two statistics types can differ: a short disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.



Footnotes:
1. US Census Bureau, Population Estimates, 2004
2. US Census Bureau, International Data Base, 2004
 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise